| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Jan―31 |
New (2Z)-1-(2,4-dinitrophenyl)-2-[(2E)-3-(2-nitrophenyl)prop-2-en-1-ylidene]hydrazine and its V(II) and Ni(II) complexes: synthesis, characterization and in silico sars-CoV-2 inhibition studies |
K. O. Eberendu, C. I. Nwankwo, O. M. Mac-kalunta, J. I. Iheanyichukwu, I. E. Otuokere, J. C. Nnaji, I. O. Abaleke |
| 2 |
[GO] |
2024―Mai―02 |
TCS/ZnCl2 as a controlled reagent for the Michael addition and heterocyclic cyclization based on the phenyl pyrazolone scaffold with docking validation as a Covid-19 protease inhibitor |
Abdulrahman A. Almehizia, Ahmad M. Naglah, Amer A. Zen, Tamer K. Khatab, Ashraf S. Hassan |
| 3 |
[GO] |
2022―Dez―21 |
Computational molecular docking and in silico ADMET prediction studies of pyrazole derivatives as Covid-19 main protease (MPRO) and papain-like protease (PLPRO) inhibitors |
Tamer K. Khatab, Ashraf S. Hassan |
| 4 |
[GO] |
2022―Dez―21 |
Zeolite A/ZnCl2 nanoparticles as a catalyst for eco-friendly synthesis of pyrazole-1- carbothioamides with docking validation as Covid-19 main protease (MPRO) inhibitor |
Norhan M. Younis, Amr M. Abdelghany, Fathy Shaaban, Tamer K. Khatab, Ehab Abdel-Latif, Heba M. Metwally |
| 5 |
[GO] |
2022―Dez―21 |
Novel series of thiazole-based complxes; characterization, structural optimization, in-vitro and in-silico assessments against Covid-19 virus compared to Palxlovid drug |
Riman K. Alnefaie, Khlood Abou-Melha, Nashwa El-Metwaly |
| 6 |
[GO] |
2022―Mai―20 |
Studies of quantum mechanics/molecular docking on zanubrutinib as potential repurposed against Covid-19 |
Nosrat Madadi Mahani, Sayed Zia Mohammadi |
| 7 |
[GO] |
2022―Jan―31 |
Spectral characterization and biological studies of some ternary complexes with molecular docking investigations against MERS and SARS type coronaviruses |
V. P. Saikishore, S. K. Biswal, R. K. Mohapatra |
| 8 |
[GO] |
2021―Okt―25 |
Preparation, spectroscopic, thermal and molecular docking studies of covid-19 protease on the manganese(II), iron(III), chromium(III) and cobalt(II) creatinine complexes |
M. Y. El-Sayed, M. S. Refat, T. Altalhi, H. H. Eldaroti, K. Alam |
| 9 |
[GO] |
2021―Mai―10 |
Copper-based glass-ceramic as an efficient catalyst in the synthesis of pyrazolo[1,5-a] pyrimidineunder solvent-free condition with docking validation as Covid-19 main protease (Mpro) inhibitor |
A. M. Abdelghany, T. K. Khatab, A. S. Hassan |
| 10 |
[GO] |
2021―Jan―12 |
Interactions mechanism of commonly used drugs for the treatment of Covid-19 |
S. Celik, A. D. Demirag, A. E. Ozel, S. Akyuz |
